Dr. David Rabin MD, PhD and Kathryn Fantauzzi

Founders of Apollo Neuroscience Inc.

Dr. David Rabin MD, PhD and Kathryn Fantauzzi are the founders of Apollo Neuroscience Inc. Apollo is the first clinically validated wearable that helps your body adapt to stress, facilitating focus, sleep, energy, calm, and more.

 

Kathryn Fantauzzai is the CEO and co-founder of Apollo Neuroscience. Prior to Apollo Neuro, Kathryn helped develop and launch a $20M early technology commercialization accelerator through the New York State Energy Research and Development Authority (NYSERDA) to identify, incubate, and fund early-stage technology companies in order to advance the adoption of their innovations.

 

Dr. Rabin is a board-certified psychiatrist, translational neuroscientist and inventor, and has been studying the impact of chronic stress in humans for more than 10 years. He has specifically focused his research on the clinical translation of non-invasive therapies that improve mood, focus, sleep and quality of life in treatment-resistant illnesses.

 

Follow Apollo Neuro:

WebsiteInstagram  • Facebook  • TwitterLinkedin

SATURDAY: PSYCHEDELIC TECH